AI assistant
Cardlytics, Inc. — Director's Dealing 2020
May 13, 2020
33956_dirs_2020-05-13_f1acb70d-3f37-4e58-a242-24663262500f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-05-12
Reporting Person: Laube Lynne Marie (Director, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-12 | Common Stock | S | 1000 | $59.85 | Disposed | 17565 | Indirect |
| 2020-05-12 | Common Stock | S | 1000 | $59.85 | Disposed | 17565 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 283001 | Direct |
Footnotes
F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustees of the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright (the "KGA GRAT") on May 14, 2019.
F2: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
F3: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustees of the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright (the "HMA GRAT") on May 14, 2019.
F4: The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.